Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global contraceptive drugs market size was valued at USD 13,097.7 Million in 2017 and is projected to reach USD 20,200.5 Million by 2025, exhibiting a CAGR of 5.8% in the forecast period (2018-2025).

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Contraceptive Drugs market.

Trusted Business Insights presents an updated and Latest Study on Contraceptive Drugs Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Contraceptive Drugs market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Contraceptive Drugs Market Size, Share and Industry Analysis By Product Type (Oral, Injectable & Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

The global contraceptive drugs market size was valued at USD 13,097.7 Million in 2017 and is projected to reach USD 20,200.5 Million by 2025, exhibiting a CAGR of 5.8% in the forecast period (2018-2025).

We have updated Contraceptive Drugs Market with respect to COVID-19 Impact.
Inquire before buying

According to the United Nations Organization, approximately 800 million married or in-unison women are projected to be using contraception by 2030. Ensuring access to contraceptive methods for women is essential in securing the autonomy of women and it reduces the rate of deaths from early childbearing. Relatively fewer complications, ease of reversibility and positive menstrual effects are some of the advantages of contraceptive drugs over other alternative methods which have resulted in the demand for contraceptive drugs.

Active government participation in the promotion of women health and the importance of family planning, especially in emerging nations, is a key factor associated with the growth of global contraceptive drugs market. Moreover, the improved distribution channels for contraceptive drugs through government-aided pharmacy is also encouraging its consumption.

“”Increased Research and Proactive Government Initiatives to Fuel the Demand for Contraceptive Drugs””
The increasing population and concern for womens health has triggered the government to launch various women health policies and awareness schemes to promote use of contraceptive drugs. Free distribution of drugs and counseling by the doctors in government-aided hospitals to promote family planning is anticipated to drive the contraceptive market.

Furthermore, the increased research for the development of new drugs is also expected to fuel the global contraceptive drugs market. For example, in November 2018, The Population Council, Los Angeles Biomedical Research Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and University of Washington School of Medicine launched first clinical study to test the efficacy and safety of a gel to be used by men for the prevention of unintended pregnancy.

According to WHO, around 214 million women belonging to reproductive age in developing countries who want to avoid pregnancy are deprived of modern contraceptive method. These huge unmet needs are projected to provide new growth opportunities for the global contraceptive drugs market.

Market Segmentation

Based on the product type, the global contraceptive drugs market segments include oral, injectable, and patches. Oral contraceptive drugs comprise of combined contraceptives and progestin-only pills. Rising uptake of oral contraceptives worldwide and their ease of availability are responsible for propelling the sale of oral contraceptive drugs at a remarkable rate.

Oral contraceptives segment is expected to remain dominant by the end of 2025. The oral contraceptive pills are given free of cost to women under the Affordable Care Act (ACA) in the U.S., which is another factor accelerating the oral contraceptive drugs market value.

Based on distribution channels, the global contraceptive drugs market segment include hospital pharmacy, retail pharmacy, clinics, online channel, public channel & NGO, and others. Retail pharmacy is expected to emerge as a major source for the contraceptive drugs, owing to the significant increase in the over-the-counter purchase of the contraceptive drugs.

Regional Analysis

“”Rapid Rise in Demand for Cost-effective Contraceptives in Densely Populated Countries Such as China and India is Augmenting the Market in Asia Pacific with Maximum CAGR””
North America accounted for a contraceptive drugs market revenue of US$ 6,596.2 Mn in 2017 and is projected to continue its dominance in the market during the period of 2018-2025, which is attributable to the lowered age of contraceptive drugs users in the U.S. and Canada.
North America Contraceptive Drugs Market Share, 2017

However, in terms of growth rate, Asia Pacific is likely to grow with significant CAGR during the forecast period, owing to active government initiatives for birth control measures in order to tackle the rising population in India and China. Also, improved domestic distribution network through government-aided pharmacy and NGOs in India are the key factors associated with the estimated rise in the contraceptive drugs market size in Asia Pacific with significant CAGR during the forecast period. The contraceptive drugs market in Latin America and Middle East and Africa is anticipated to expand owing to the impoving health infrastructure and health investment.

Key Market Drivers

“”Merck & Co., Inc., Pfizer, Inc., and Allergan Plc Leading the Global Contraceptive Drugs Market””
The current global contraceptive drugs market is fragmented with numerous local and regional players. The major contraceptive drugs market share is captured by Merck & Co., Inc., Pfizer, Inc., and Allergan Plc. However, the recent recall of a major contraceptive drugs product Taytulla by Allergan Plc is expected to affect its position in the global market.

Ongoing clinical trials on birth control medications in the U.S & Europe and R&D funding by public players for the development of efficient birth control measures are the key factors associated with the estimated rise in the number of players in global contraceptive drugs market during 2018-2025. Other prominent players operating in the global contraceptives market are Janssen Pharmaceutical Company, Teva Pharmaceuticals Industry, Mylan, Novartis AG, Lupin Pharmaceuticals Ltd, Bayer AG, Agile Therapeutics, etc.

List of Companies Profiled

  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Allergan Plc
  • Agile Therapeutics
  • Piramal Enterprises Ltd.

Report Coverage

Contraceptive drugs are medications used for the prevention of unwanted pregnancy. Contraceptive drugs are available in the form of oral pills, injections, and patches and have established their dominance as a means of emergency contraception. Use of contraceptive drugs can reduce the risk on womens health due to early childbearing, unsafe abortion, and infant mortality rate.

The report provides qualitative and quantitative insights on the contraceptive drugs industry trends and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented by product type and distribution channel. On the basis of product type, the global contraceptive drugs market is categorized into oral (combined contraceptives and progestin-only pills), injectable, and patches. Various distribution channels for contraceptive drugs include hospital pharmacy, retail pharmacy, clinics, online channel, public channels & NGOs, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.

Along with this, the report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are fertility statistics for key countries, new product launch, pipeline analysis, recent industry developments such as partnerships, mergers and acquisitions, and regulatory scenarios for key countries.

SEGMENTATION

By Product Type 

  • Oral
  • Combined Contraceptives
  • Progestin-only Pills
  • Injectable
  • Patches

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Public Channel & NGOs
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Development

In November 2018, The Population Council, Los Angeles Biomedical Research Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and University of Washington School of Medicine launched first clinical study to test the efficacy and safety of a gel to be used by men for the prevention of unintended pregnancy

In August 2018, Lupin Pharmaceuticals announced the launch of Drospirenone, Ethinyl Estradiol, and Levomefolate Calcium tablets contraceptive drugs in the U.S.

In May 2018, Aurobindo Pharma launched MILI and TRI-MILI oral contraceptive tablets for use in women to avoid conception.

In April 2018, Mylan N.V., launched generic YAZ oral contraceptive drug for use by women to avoid unintential pregnancy.

 

Looking for more? Check out our repository for all available reports on Contraceptive Drugs in related sectors.

Quick Read Table of Contents of this Report @ Contraceptive Drugs Market Size, Share and Industry Analysis By Product Type (Oral, Injectable & Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global wearable medical devices market size was valued at USD 24,571.8 Million in 2018 and is projected to reach USD 139,353.6 Million by 2026, exhibiting a CAGR of 24.7% in the forecast period (2019-2026).

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Wearable Medical Devices market.

Trusted Business Insights presents an updated and Latest Study on Wearable Medical Devices Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Wearable Medical Devices market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Wearable Medical Devices Market Size, Share and Industry Analysis By Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

The global wearable medical devices market size was valued at USD 24,571.8 Million in 2018 and is projected to reach USD 139,353.6 Million by 2026, exhibiting a CAGR of 24.7% in the forecast period (2019-2026).

We have updated Wearable Medical Devices Market with respect to COVID-19 Impact.
Inquire before buying

Healthcare industry is witnessing extensive adoption of connected devices. Rapidly increasing prevalence of chronic disease, superior treatment and diagnostic outcomes, and increasing integration of technology and healthcare is accelerating the acceptance of wearable medical devices across the globe. Certain new technologies such as IoT (Internet of Things) and others can retrieve real time patient data which is utilized by physicians to predict the health conditions of patients.

For instance, in September 2018, UbiHealth, a Switzerland-based MedTech startup has recently developed a remote patient monitoring patch, which has the capability to analyze vital conditions of the patients, also it can transfer real time information to the concerned physician with the help of cloud. Exponentially increasing population across the globe is generating need of intelligent technologies with the aim to cope with limited number of healthcare resources.
“”Increasing patient pool coupled with growing per capita healthcare expenditure is projected to boost the global wearable medical device market revenue””

According to a study conducted by United Nations, an estimated 1 in 6 people in the world will be over age 65 by 2050. Moreover, according to the study, 1 in 4 people in North America and Europe will be over 65 during the same course of time. Aging population across the globe is prominently projected to accelerate the expansion the global market during the forecast period.

Additionally, such rate of aging population combined with increasing patient pool in emerging nations is offering lucrative opportunity for extensive adoption of patient monitoring and diagnostic wearable medical devices. Moreover, certain economic factors such as increasing per capita healthcare expenditure, developing healthcare infrastructure, and increasing investment of industry sector for the development of innovative technologies are anticipated to boost the wearable medical devices market growth by 2026.
Market Segmentation

Based on product, the global market segments includes diagnostic & monitoring wearable medical devices and therapeutic wearable medical devices. Diagnostic & monitoring wearable medical devices are projected to hold significant portion of the global market share during the forecast period. On the basis of application, the wearable medical devices market is segmented as remote patient monitoring, sports & fitness, and home healthcare. Based on the distribution channel, the market segment includes retail pharmacies, online pharmacies, and hypermarkets.

Regional Analysis

“”Favorable HIPAA (Health Insurance and Portability and Accountability Act) policies combined with advanced healthcare infrastructure in enabling the growth of the market in North America””

North America generated a revenue of USD 10,146.3 Million in 2018. North America is witnessing gradual shift of patient preference from traditional physician interaction to remote interaction. Moreover, favorable regulatory policies for the development of fitness wearable as well as patient monitoring devices are anticipated to boost the growth of the North America wearable medical devices market by 2026.

In Europe, aging population coupled with exponentially increasing chronic diseases are offering lucrative opportunity for accelerated adoption of these devices, which will eventually fuel the growth of the wearable medical device market in Europe during the forecast period. Asia Pacific is anticipated to witness higher market CAGR as compared to other regions owing to the growing adoption of devices such as activity monitors, smartwatches, pain management devices, and others. Moreover, rising emphasis on reduction in patient hospital stay in emerging nations such as China and India are expected to drive the market in Asia Pacific.
North America Wearable Medical Devices Market Size, 2018

Key Market Drivers

“”Fitbit, Apple, Sonova, Samsung, and Philips Healthcare Are Expected to Hold Considerable Share in the Wearable Medical Devices Market””

Giant organizations such as Fitbit, Apple, Sonova, and Philips Healthcare are expected to lead the global wearable technology market during the forecast period. Robust focus on innovation coupled with continuous product development, increasing investments in research & development and cost management are projected to serve huge opportunity for the mentioned market players to lead the wearable medical devices market share during the forecast period. Moreover, the market is expected witness intense competitive landscape owing entry of already established market players and new medical technology startups during the forecast period.

List of Key Companies Profiled

  • Fitbit, Inc.
  • Apple Inc.
  • BD
  • Ypsomed AG
  • Sonova
  • Hologic Inc.
  • AiQ Smart Clothing
  • NeuroMetrix, Inc.
  • Siemens Healthcare GmbH
  • SAMSUNG
  • Other players

Report Coverage

Wearable devices are often utilized to track real-time vital signs of patients. The data generated by wearable devices add value to the early disease diagnosis, treatment outcomes, remote patient monitoring, and other types of healthcare aspects. The popularity of wearable medical devices is continuously increasing in life sciences due to its extensive applications, promising solutions, and methodologies for disease diagnosis on a molecular level.
The report provides both qualitative and quantitative insights on wearable medical devices industry trends and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented into product, application, and distribution channel. On the basis of the product, the wearable medical devices market is categorized into diagnostic & patient monitoring and therapeutic wearable devices.

Diagnostic & patient monitoring wearable medical devices are further segmented as activity monitors/trackers, smartwatches, smart clothing, and others. Based on the therapeutic category, the market is segmented as wearable defibrillators, drug delivery devices, pain management devices, hearing aids, and others.
Based on applications, the market is segmented as remote patient monitoring, sports & fitness, and home healthcare. On the basis of distribution channel, the global market is segmented as retail pharmacies, online pharmacies, and hypermarkets. Geographically, the market is segmented into major regions, which are North America, Europe, Asia Pacific, and Rest of the World. These regions are further categorized into countries.
Along with this, the wearable medical devices market report includes market dynamics and a competitive landscape. Various key insights provided in the report are Porter’s five forces analysis, recent advancements in wearable medical devices, key mergers & acquisitions, and others.

SEGMENTATION

 By Product

Diagnostic & Patient Monitoring Wearable Medical Devices

  • Activity Monitors/ Trackers
  • Smartwatches
  • Smart-clothing
  • Others (Biosensors, blood pressure monitors, glucose monitoring systems)

Therapeutic Wearable Medical Devices

  • Wearable Defibrillators
  • Drug Delivery Devices (Injectors, Patches)
  • Pain Management Devices (TENS, EMS)
  • Hearing Aids
  • Others

By Application

  • Remote Patient Monitoring and Home Healthcare
  • Sports and Fitness

By Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies
  • Hypermarkets

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Rest of the World

Key Industry Developments

In May 2019, Nemaura got CE approval for its SugarBEAT, a wearable continuous glucose monitoring device.

In July 2018, CeQur, a Swiss-based medical technology company acquired Johnson & Johnson’s Calibra Insulin delivery patch. The company took a strategic decisions to add an advanced insulin delivery device in its product portfolio.

In January 2018, L’Oréal S.A launched an advanced UV ray tracking device to measure the UV exposure of the wearer. The company made a strategic moves to enter into the wearable devices segment.

 

Looking for more? Check out our repository for all available reports on Wearable Medical Devices in related sectors.

Quick Read Table of Contents of this Report @ Wearable Medical Devices Market Size, Share and Industry Analysis By Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global commercial seaweed market size valued at USD 11.48 billion in 2017 and is projected to reach USD 21.75 billion by the end of 2025, exhibiting a CAGR of 8.42% in the forecast period.

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Commercial Seaweed market.

Trusted Business Insights presents an updated and Latest Study on Commercial Seaweed Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Commercial Seaweed market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Commercial Seaweed Market Size, Share and Industry Analysis By Product Type (Red Seaweed, Brown Seaweed, Green Seaweed), By Form (Flakes, Powder, Liquid), By End User (Food and Beverage, Agricultural Fertilizer, Animal Feed Additives, Pharmaceuticals, Cosmetics and Personal Care), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

The global commercial seaweed market size valued at USD 11.48 billion in 2017 and is projected to reach USD 21.75 billion by the end of 2025, exhibiting a CAGR of 8.42% in the forecast period.

We have updated the Commercial Seaweed Market with business impact analysis and disruption caused by COVID-19.
Inquire before buying

Commercial seaweed, also known as marine algae, come in a variety of colors such as red, brown, and green. Commercial seaweed has been utilized around the world for many centuries and was also considered to be a source of food in a few coastal communities. seaweed is widely used in the food and beverage industry for its hydrocolloid properties and has various applications in other industries such as pharmaceuticals, agricultural products, animal feed additives, cosmetics, and personal care products.
The commercial seaweed market is projected to grow at a rapid pace over the forecast period due to increased demand for seaweeds by the food industry. The escalation in production and demand of commercial seaweed hydrocolloids such as carrageenan, alginate, and agars due to their increased application in dairy, meat and poultry processing, jelly, desserts, canned fish, animal feed, pharmaceutical, textiles, and other industries is expected to contribute significantly to market growth. Health benefits associated with the consumption of seaweed products are also motivating people to include seaweed in their daily food. Fluctuation in prices and supply-demand variations can obstruct the growth of the market during the forecast period.

Food and beverage industry stakeholders have recognized the biomass originating from algae as an alternative protein source to secure the global food and protein demand. Commercial seaweeds or microalgae or marine algae have significant potential in the food and beverage industry, owing to the presence of health benefit contents and its various functional properties. due to these valuable properties, commercial seaweed farming is booming nowadays globally.

Commercial seaweed has various macro and micronutrients in it, such as sodium, potassium, magnesium, calcium, copper, zinc, chlorine, sulfur, phosphorous, and other nutrients. There are more than 200 species of seaweed types cultivated or naturally grown, in which few of them are explored commercially for their beneficial properties in various industries.

“”The Cosmetics & Personal Care Industry is Forecasted to Exhibit Strong Growth””
By the end-user segment, the food and beverage industry is expected to hold the largest share in terms of value in the commercial seaweed market throughout the forecast period, owing to the high demand for its various functional properties in the food products. Seaweed has various applications in cosmetics and personal care industry due to its antioxidants properties and is used as an ingredient in many of the products such as body lotions, moisturizing soaps, and creams, hair creams, and shampoos.

The derivatives or extracts of seaweeds function in stimulating cells act as moisturizing agents. Considering the increasing uses of seaweed in the cosmetics and personal care products, growth of the end-use segments is projected to support the healthy growth of consumption of seaweed in cosmetics and personal care industry during the forecast period from 2018 to 2025 in the overall market.

Aquafarming highly depends on the marine wild catch for fish meal and oil as feed and nearly 17-18% of the global catch fish is converted into fish meal and oil to feed the farmed fish and other animals. According to the FAO, 70% of the fish meal and 73% of the fish oil is consumed by the aquaculture industry, and the fishmeal production declined by 2.4% during the period from 2005 to 2015 mainly due to shifting in demand from the aquaculture industry.
The increasing need for protein and the high cost of fish meal and oil in recent years has created the need for alternatives in the aquafarming. The presence of a wide range of physiological and biochemical characteristics, microalgae or seaweed is identified as a sustainable alternative for the needs of aquaculture as feed. Companies such as ADM, DSM, Corbion, and Evonik are involved in producing microalgae-based feed products as alternatives to fish meal and oil.

“”Amplified Demand for Hydrocolloids from the Food & Beverage Industry””

The demand for commercial seaweed from the food industry across the globe is rising due to the product efficiency in adding value to the food products. Alginate, agar, and carrageenan extracts are the common seaweed extracts that are used as gelling, stabilizing, emulsifying, and thickening agent in various food products, such as ice-cream, jam, fruit juices, bakery products, and others.

Food manufacturers are actively in search of functional ingredients to develop novel functional foods. Seaweeds being a rich source of diversity of biochemicals, such as amino acids, proteins, lipids, vitamins, polysaccharides, peptides, and minerals, are efficient of exerting bioactivities in food, hence increasing its functionality as well as market value. This factor is expected to ramp the commercial seaweed market growth. For instance, in July 2018, Cargill Inc. launched Satiagel Seabird, a new variety of carrageenan extract that is based on 100% cultivated seaweed and can help dairy manufacturers achieve premium textures for creamy dairy desserts.
Asia Pacific Commercial Seaweed Market Share, 2017

According to research findings, a strong growth trajectory has been observed in the launch of seaweed-flavored food & beverage products across developed regions, especially in Europe. Increased focus on R&D activities and cultivation technology of seaweeds is expected to accelerate the growth of the market during the forthcoming years.

Key Market Drivers

“”Cargill and CP Kelco to Account for More than Half of the Market Share in Terms of Revenue””
Cargill, Inc. & CP Kelco have emerged as leading players with a large market share in 2017 in the commercial seaweed market. The companies R&D investments helped in launching new products to meet the growing requirement among consumers. Large companies in the industry are majorly focusing on R&D and product innovation and developments while outsourcing the production and processing operations of seaweed to small companies through the agreement for long-term trade relationships.

List of Key Companies Profiled

  • DowDuPont Inc. (Danisco)
  • Cargill, Inc.
  • CP Kelco
  • Corbion
  • Kerry Group PLC
  • FMC Corporation
  • Acadian Seaplants Limited
  • Gelymar S.A.
  • Ocean Harvest Technology Limited
  • Roullier Group

Report Coverage

The market report provides qualitative and quantitative insights on the commercial seaweed industry and detailed analysis of commercial seaweed market size and growth rate for all possible segments in the market. The market is segmented by type, form, and end-use. On the basis of type, the market is categorized into red seaweed, green seaweed, and brown seaweed. Based on the form, the global market is segmented into flakes, powder, and liquid.

Various end uses covered in the report are food and beverage, animal feed additives, agricultural fertilizers, pharmaceuticals, and cosmetics and personal care. Geographically, the market is segmented into five major regions which are North America, Europe, Asia Pacific, South America, and Middle East & Africa. The regions are further categorized into countries.

Along with this, the commercial seaweed market report provides an elaborative analysis of the market dynamics and competitive landscape. The report provides insights into the overview of hydrocolloids industry, health benefits of commercial seaweed, recent industry developments such as mergers & acquisitions, trade analysis and the regulatory scenario in key countries, and key industry trends.

SEGMENTATION

 

By Type

  • Red Seaweed
  • Brown Seaweed
  • Green Seaweed

By Form

  • Flakes
  • Powder
  • Liquid

By End Uses

  • Food and Beverage
  • Agricultural Fertilizers
  • Animal Feed Additives
  • Pharmaceuticals
  • Cosmetics and Personal Care

By Geography

  • North America (U.S. Canada, and Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Belgium, Russia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific)
  • South America (Brazil, Argentina, and Rest of South America)
  • Middle East & Africa (South Africa, UAE, and Rest of the Middle East & Africa)

Key Industry Developments

In June 2018, Ocean Harvest Technology Limited, a leading producer of animal feed ingredients launched OceanFeed Swine, a seaweed-based, all-natural animal feed ingredient. The product claims to aid in improving the health of animals and their productivity.

In May 2017, Cargill Inc. launched a novel type of carrageenan extract, Satiagel Seabird, developed from 100% cultivated seaweed. The product is specially formulated to aid dairy manufacturers to achieve the desired creamy texture, which is required in various dairy desserts.

 

Looking for more? Check out our repository for all available reports on Commercial Seaweed in related sectors.

Quick Read Table of Contents of this Report @ Commercial Seaweed Market Size, Share and Industry Analysis By Product Type (Red Seaweed, Brown Seaweed, Green Seaweed), By Form (Flakes, Powder, Liquid), By End User (Food and Beverage, Agricultural Fertilizer, Animal Feed Additives, Pharmaceuticals, Cosmetics and Personal Care), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global ePharmacy market size was valued at USD 49,727.7 Million in 2018 and is projected to reach USD 177,794.9 Million by 2026, exhibiting a CAGR of 17.3% in the forecast period (2019-2026).

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the ePharmacy market.

Trusted Business Insights presents an updated and Latest Study on ePharmacy Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the ePharmacy market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ ePharmacy Market Size, Share and Industry Analysis By Product (Over-the-Counter Products, Prescription Medicine) and Regional Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

The global ePharmacy market size was valued at USD 49,727.7 Million in 2018 and is projected to reach USD 177,794.9 Million by 2026, exhibiting a CAGR of 17.3% in the forecast period (2019-2026).

We have updated ePharmacy Market with respect to COVID-19 Impact.
Inquire before buying

There is an ever-increasing demand for mail-order medicines with the increasing penetration of e-commerce and use of the Internet. Many online pharmacies, otherwise known as ePharmacy around the globe offer doorstep delivery and dispensing of prescription medicines and over-the-counter products. However, ordering and dispensing of a prescription drug through online channel requires a prescription from a medical practitioner. With the onset of ePharmacy, patients do not have to travel to the pharmacist.

Additionally, major ePharmacy companies provide medicines in discounted rates compared with other traditional brick and mortar pharmacy stores. The ePharmacy market trend is estimated to experience an exponentially growing CAGR of 17.3% in the upcoming 6 -7 years owing to the increasing investment of e-commerce giants in the field of healthcare. For Instance, in June 2018, Amazon.com, Inc. announced the companys plans to acquire ePharmacy company PillPack, Inc. for approximately US$ 753 Mn.
Key Market Drivers

“”The efficiency of ePharmacies in delivering low-cost medical products, and combined with the increasing penetration of e-commerce is driving the global ePharmacy market growth””

A large patient pool globally prefers doorstep delivery of healthcare products owing to unavailability of certain medicines in retail pharmacy stores. Additionally, ePharmacies lower the dependency of chronically ill patients and elderly citizens towards third person for procurement of medicines and healthcare supplies. Additionally, the increasing penetration and literacy regarding internet resources are projected to boost the market sales.
The growing reach of e-commerce has facilitated the ePharmacy to capture a wide customer base in the developed and developing countries of the world. Millennials of this generation are highly reliant on the online procurement of goods like cosmetics and over the counter medicines. There are also various startups springing up around the globe due to the advent of new information technologies and algorithms that offer better consumer experience and satisfaction. New technologies based on artificial intelligence is estimated to ensure better customer satisfaction in market. All these factors cumulatively are expected to drive the global ePharmacy market growth.

Conversely, there are stringent regulations for selling prescription drugs through online channels. Prescription drug sales through ePharmacy in North America and Europe are highly regulated, and the companies have to comply with various rules, which could impact the market growth in these regions. Additionally, not all the countries in the world have legalized sales of prescription drugs through online sites. Factors such as unregularised sale of prescription medicines that could lead to prohibition of online pharmacy are estimated to restrain the global market revenue.
Market Segmentation

Based on the product, the global market segments include prescription medicine and over-the-counter products. The over-the-counter segment dominated the ePharmacy industry in 2018. The prescription medicine segment accounted for the a lower share of the market in 2018 but is estimated to grow at a faster CAGR during the forecast period. Based on geography, the market segments include North America, Europe, Asia Pacific, and Rest of the World.

Regional Analysis
“”A rising number of internet users and higher dependency on e-commerce goods are anticipated to boost the ePharmacy industry growth in the North America””

In North America, the over-reliance of the general population on the online delivery of consumable goods including over-the-counter healthcare products like vitamin tablets, nutrition supplements, and cosmetic among others are projected to positively influence the ePharmacy market trend. A rise in the number of patients adopting home care treatment and services owing to high healthcare expenditure in hospitals are estimated to increase the online procurement of medicines in North America.

The market in North America is well established and have captured wide population base owing to high penetration of the Internet. Additionally, the Food and Drug Administration (FDA) in the U.S focuses on actively informing the citizens regarding the rules and regulations of ePharmacy and making them aware about the safety of buying drug online. The Europe market is highly regulated by the European Commission with stringent guidelines; however, the global market is estimated to witness growth owing to the lucrative price offering by major companies operating in the market.

North America ePharmacy Market Size, 2018

The market in Asia Pacific are projected to demonstrate a comparatively higher CAGR during the forecast period, owing to rising penetration of the Internet and higher adoption of e-commerce websites. The market in the rest of the world that includes countries of Latin America and Middle East & Africa accounted for a comparatively small ePharmacy market share for the year 2018 owing to lower literacy regarding ePharmacy however, it is expected to experience a considerable CAGR owing to the unmet needs of online distribution of medicines.
Key Market Players

“”CVS Health Corporation, Doc Morris, and Express Scripts Holding Company dominated the global ePharmacy market in 2018

The market is a semi-consolidated market with the top five players accounting for a significant share of the market in 2018. A deep-rooted product presence in the ePharmacy, along with a strong distribution channel, has been contributory to the dominance of these players in the market. Additionally, the established market presence and trust of the consumers have facilitated the dominance of the top market players in ePharmacy.

On the flip side, other market players are expanding their presence in ePharmacy, combined with a focus on the expansion through the geographic presence and strengthening their distribution channel with mergers and acquisition with local players. These players are expected to gain significant ePharmacy market share during the forecast period. The rising completion within the companies operating in the ePharmacy industry is estimated to affect the market share of the key players.

List of Companies Profiled

  • DocMorris
  • CVS Health Corporation
  • Express Script Holding Company
  • Walgreen Co.
  • Optum Rx, Inc.
  • Giant Eagle, Inc.
  • Walmart Stores, Inc.
  • Rowland Pharmacy
  • The Kroger Co.
  • Other players

Report Coverage

According to the World Bank, around 75% of the population in the U.S are internet subscribers, and around 84 % population in Germany are reliant on internet. This large population dependent on internet for the procurement of commodities combined with the lucrative price offerings by major players are leading to rising demand for ePharmacy globally. The introduction of new players in the ePharmacy market combined with rising competition globally is projected to further augment the growth for ePharmacy during the forecast period.

The report provides qualitative and quantitative insights on the ePharmacy industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market segments include product and geography. On the basis of the product, the market segments include prescription medicines and over-the-counter products. Geographically, the global market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and rest of the world. The regions are further categorized into countries.

Along with this, the report analysis includes ePharmacy industry dynamics and competitive landscape of the market. Various key insights provided in the report are key start-ups and funding overview, recent industry developments such as mergers & acquisitions for 2018, an overview of regulatory scenario – key countries, key industry trends, and an overview of e-commerce penetration – key countries.

Segmentation

 

By Product

  • Over-the-Counter Products
  • Prescription Medicine

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Rest of Asia Pacific)
  • Rest of the World

Key Industry Developments

In January 2019, Swedish online pharmacy company Meds, bagged a US$ 5.5 Mn funding to expand its business across Europe. This funding is estimated to increase the focus of the company in expanding its reach in other European countries.

In June 2015, Rite Aid Corp acquired Envision Rx Options that provides mail-order pharmacy services including prescription medicines. This acquisition facilitated Rite Aid Corp to enter into the field of ePharmacy.

In March 2019, 1mg, an Indian online pharmacy garnered LegitScript certification from the National Association of Boards of Pharmacy (NABP), USA making it the first company in India to earn the said certification. The certification will increase the trust of the customers in the company products.

U, Netmeds Marketplace Limited announced the acquisition of hyperlocal drugs delivery app named Pluss for an undisclosed amount. This acquisition will enable the company to focus on enhancing the companys online app.

 

Looking for more? Check out our repository for all available reports on ePharmacy in related sectors.

Quick Read Table of Contents of this Report @ ePharmacy Market Size, Share and Industry Analysis By Product (Over-the-Counter Products, Prescription Medicine) and Regional Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global medical imaging equipment market size was valued at USD 30,814.2 Million in 2017 and is Projected to be Valued at USD 44,077.7 Million by 2025, Exhibiting a CAGR of 4.6% From 2018-2025.

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Medical Imaging Equipment market.

Trusted Business Insights presents an updated and Latest Study on Medical Imaging Equipment Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Medical Imaging Equipment market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Medical Imaging Equipment Market Size, Share and Industry Analysis by Type (Magnetic Resonance Imaging Equipment, Computed Tomography Equipment, X-ray Equipment, Ultrasound Equipment Molecular Imaging Equipment), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology), By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Others) and Regional Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

The global medical imaging equipment market size was valued at USD 30,814.2 Million in 2017 and is Projected to be Valued at USD 44,077.7 Million by 2025, Exhibiting a CAGR of 4.6% From 2018-2025.

We have updated Medical Imaging Equipment Market with respect to COVID-19 Impact.
Inquire before buying

Increasing incidence of chronic and lifestyle diseases including cancer, cardiovascular diseases, and orthopedic disorders among the general population is presenting a large patient pool undergoing diagnostic imaging procedures globally. A rapidly aging population especially in Europe and Asia Pacific countries is presenting a pool of patient population suffering from age-related disorders.
This, combined with an increasing emphasis of regional and national governments towards early diagnosis aiming to reduce overall healthcare costs, is driving the number of patients undergoing MRI, CT and X-ray scans globally. The global medical imaging equipment market is projected to exhibit moderate CAGR during the forecast period.

Market Segmentation

“”Rising Demand for Ultrasound Equipment in Emerging Countries Driving the Segment in 2017″”

Market players operating in the global medical imaging equipment market, are constantly focused towards offering innovative products with improved functional and clinical benefits, with an aim to keep up to the pace of ever-rising demands of the market. New ergonomic models with clinical supremacy being introduced in the market such as portable ultrasound, C-arms with X-ray flat panel detectors and 7T MRI machines, are a result of the unmet needs and growing demands for advanced equipment from healthcare settings globally. Among the types, the ultrasound equipment segment accounted for 22.9% share of the market in 2017.

On the basis of application, the global market is segmented into oncology, cardiology, orthopedics, gynecology, neurology, and others. Increasing incidence of cancer globally, along with a rising emphasis on early detection and diagnosis of cancer, and improving access to healthcare facilities and diagnostic imaging centers in emerging countries, are some of the major factors projected to drive the comparatively higher CAGR of oncology application segment in the medical imaging equipment market during 2018-2025.

On the basis of the end user, the market is segmented into hospitals, specialty clinics, diagnostic imaging centers, and others. An increasing number of diagnostic imaging centers in developed and emerging countries owing to consolidation in the global market is projected to drive the diagnostic imaging centers in the global market.

Regional Analysis

“”Higher Adoption of New and Technologically Advanced Systems in the U.S., is Driving the Market in North America””

In November 2018, Siemens Healthcare GmbH introduced two new magnetic resonance imaging scanners at the Radiology Society of North America (RSNA 2018) conference. The two new scanners are based on the proprietary Biomatrix technology concept of Siemens Healthcare GmbH.

New products being offered in the market, combined with an aging installed base of medical imaging equipment in the U.S., is leading to increasing adoption of advanced systems in the country. This, along with the increasing number of patients undergoing diagnostic imaging procedures in the country, is propelling the medical imaging equipment market growth in the U.S.

Chinese manufacturers and other regional players entering the lucrative U.S. market is projected to further augment the medical imaging equipment market growth in North America. The region generated revenue of USD 7,993.4 Mn in 2017 and is expected to register a moderate CAGR during the forecast period.
North America Medical Imaging Equipment Market, 2017

Key Market Drivers

“”Strong Portfolio, Widespread Distribution Network, and Strong Brand Presence of Major Players Have Resulted in a Consolidated Market in 2017. “”

The market is a consolidated with top 3-5 players accounting for more than a third of the medical imaging equipment market share in 2017. General Electric Company, Koninklijke Philips N.V., and Siemens Healthcare GmbH are among the leading players in the global medical imaging equipment market in 2017. A diverse portfolio of medical imaging equipment, combined with a strong and widespread distribution network globally, are some of the major factors attributed to the dominance of these players in the global market. However, an increasing number of domestic players entering the market with innovative product offerings are anticipated to challenge the dominance of these players during 2018-2025.

Key companies covered in the report

  • GENERAL ELECTRIC COMPANY
  • Hitachi, Ltd.
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Koninklijke Philips N.V.
  • Supersonic Imagine
  • Hologic, Inc.
  • SAMSUNG
  • Fujifilm Holdings Corporation
  • Other Prominent Players

Report Overview

An aging installed base of medical imaging equipment, especially X-ray equipment, and ultrasound equipment in emerging countries, is driving the demand, and consumption of replacement unit shipments of x-ray and ultrasound equipment in these countries. This combined with a developing healthcare infrastructure in these countries is leading to increasing demand for new unit shipments of different modalities of medical imaging equipment in the global market. The global medical imaging equipment market is characterized by higher demand for replacement units from developed countries, and increasing demand for replacement and new units from emerging countries in 2017.

The report provides qualitative and quantitative insights on medical imaging equipment industry and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented as per type, application, and end user. On the basis of type, the global medical imaging equipment market is further segmented into magnetic resonance imaging equipment, computed tomography equipment, x-ray equipment, ultrasound equipment, and molecular imaging equipment.
On the basis of application, the market is segmented into gynecology, neurology, oncology, orthopedics, cardiology, and others. On the basis of the end user, the global medical imaging equipment market is segmented into hospitals, specialty clinics, diagnostic imaging centers, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.

Along with this, the report provides an elaborative analysis of market dynamics and competitive landscape. Additionally, the report offers insights on the prevalence of key disease indications (cardiovascular diseases, oncology, orthopedic diseases, etc.) for key countries/region, recent industry developments such as partnerships, mergers & acquisitions, the regulatory framework by key countries, and pricing analysis for key brands/players.

SEGMENTATION

By Type

  • ·         Magnetic Resonance Imaging Equipment
  • ·         Computed Tomography Equipment
  • ·         X-ray Equipment
  • ·         Ultrasound Equipment
  • ·         Molecular Imaging Equipment

By Application

  • ·         Cardiology
  • ·         Neurology
  • ·         Orthopedics
  • ·         Gynecology
  • ·         Oncology
  • ·          Others

By End User

  • ·         Hospitals
  • ·         Specialty Clinics
  • ·         Diagnostic Imaging Centers
  • ·         Others

By Geography

  • ·      North America (USA and Canada)
  • ·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • ·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • ·      Latin America (Brazil, Mexico and Rest of Latin America)
  • ·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Developments

In November 2018, Siemens Healthcare GmbH, announced the launch of Magnetom Altea 1.5T, and Magnetom Lumina 3T MRI scanners at the Radiology Society of North America (RSNA) meeting.

In March 2018, Koninklijke Philips N.V., announced the launch of its new 3T MRI scanner Ingenia Edition 3.0 at the European Congress of Radiology (ECR) 2018.

In March 2018, Siemens Healthcare GmbH, announced the launch of a new ultrasound system, Acuson Juniper, a compact ultrasound machine at the European Congress of Radiology (ECR 2018), held in Vienna, Austria.

 

Looking for more? Check out our repository for all available reports on Medical Imaging Equipment in related sectors.

Quick Read Table of Contents of this Report @ Medical Imaging Equipment Market Size, Share and Industry Analysis by Type (Magnetic Resonance Imaging Equipment, Computed Tomography Equipment, X-ray Equipment, Ultrasound Equipment Molecular Imaging Equipment), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology), By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Others) and Regional Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global telehealth market size valued at USD 49.8 Billion in 2018 and is projected to reach USD 266.8 Billion by 2026, exhibiting a CAGR of 23.4% between 2018 and 2026 

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Telehealth market.

Trusted Business Insights presents an updated and Latest Study on Telehealth Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Telehealth market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Telehealth Market Size, Share and Industry Analysis By Type (Products, Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Remote Patient Monitoring), By End User (Healthcare Facilities, Homecare, Others), and Geography Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

The global telehealth market size valued at USD 49.8 Billion in 2018 and is projected to reach USD 266.8 Billion by 2026, exhibiting a CAGR of 23.4% between 2018 and 2026

We have updated Telehealth Market with respect to COVID-19 Impact.
Inquire before buying

Information and communication technology holds the capability to address the challenges in providing high quality, accessible, and affordable healthcare services in developed and developing countries. Telehealth uses information and communication technology to overcome distance barriers and improve access to healthcare. Telehealth is emerging as a modern method to cater to the health needs of the patient population.

The rate of adoption of telehealth is gradually increasing, especially in the field of radiology, cardiology, and online consultation, augmenting the telehealth market growth. The market is also gearing up with increasing startups funding and launch of products, especially for telehealth services. For example, in April 2019, InTouch Health announced the launch of Solo, an end-to-end fully integrated virtual care platform, which is suitable for any user type in any healthcare setting. In addition to this, the emerging telehealth policies and telehealth services providers are poised to surge the market during the forecast period. This, in turn, will boost the telehealth market revenue over the projected horizon.

“”High Unmet Patient Needs expected to Drive the Market Growth during the forecast period “”
Telehealth has been successful in overcoming the distance barrier and ensuring healthcare delivery in remote locations. Majority of the population in underdeveloped countries live in rural areas which represents the population with unmet healthcare needs. Government of many countries is now focusing on providing healthcare facilities in rural areas through telehealth, which is one of the major factors driving the market.

Against this backdrop, the market size is likley to grow in the forecast duration. Huge start-up funding, increase in a number of service providers, strategic collaborations between major players, rapid adoption of e-consultation, and gradual increase in mobile health apps users are some of the factors likely to augment the market during the forecast period. Furthermore, introduction and rapid uptake of wearable devices which aid in remote patient monitoring are also expected to boost the global telehealth market share.

Based on the type, the global market segments include products and services. The services segment accounted for the maximum share in 2018 and is estimated to dominate the market throughout the forecast period owing to the increasing preference for teleconsultation, emerging telemedicine policies, and rapid adoption in healthcare settings.
Based on application, the global market segments include telemedicine, patient monitoring, continuous medical education, and others. Based on modality, the market segments include store-and-forward (asynchronous), real-time (synchronous) and, remote patient monitoring. Based on end user, the global market segments include healthcare facilities, homecare, and others.

Regional Analysis

“”Increasing Number of e-visits will make North America as a Dominating Segment in the Market””
North America dominated the telehealth market growth rate, with USD 21.2 Bn and is expected to continue the same throughout the forecast duration. The gradual increase in a number of e-visits and preference for online consultation is the primary reasons responsible for the expansion of the market in North America. In addition, the strategic presence of the major players in this region and favorable health reimbursement for telehealth services is anticipated to fuel the North America market.

In Europe, the market is projected to expand owing to the emerging telehealth policies and adoption of wearable remote monitoring devices. Asia Pacific is anticipated to register a remarkable growth during the forecast period owing to the improving healthcare scenario, technological advancements in digital imaging, and high rural population. Furthermore, the entry of GlobalMed Telemedicine in China after the exclusive distribution agreement in February 2017 is expected to render China as a lucrative market for telehealth. High unmet patient population and increasing healthcare spending are estimated to favor the growth of the market in Latin America and Middle East and Africa.
North America Telehealth Market Size, 2018

Key Market Players

“”Teladoc Health, American Well, and Doctor On Demand Together Accounted for the Maximum Telehealth Market Share””
Teladoc Health, American Well and Doctor On Demand are estimated to have a leading position in the market, owing to their huge client base and number of online consultation. The companies are striving for acquisitions and collaborations with domestic players to increase their market share. Some of the other player operating in the market are GlobalMed, Dictum Health, Inc., LLC, InTouch Technologies, Inc., MDLIVE Inc., Encounter Telehealth, HelloMD, SnapMD, Inc., and other players.

List of Companies Profiled

  • American Well
  • GlobalMed
  • Teladoc Health, Inc.
  • Dictum Health, Inc., LLC
  • InTouch Technologies, Inc.
  • Doctor On Demand, Inc.
  • MDLIVE Inc.
  • Encounter Telehealth
  • HelloMD
  • SnapMD, Inc.
  • Other players

Report Coverage

Telehealth is emerging as a modern method for catering to the health needs of the patient population. Telehealth refers to the use of technologies for the delivery of healthcare, medical education, public health services by connecting to multiple users located at different locations. Telehealth is a broad term which incorporates diagnosis and treatment of diseases through telemedicine, remote patient assessment, and monitoring and health education.
Telehealth includes use of various telecommunications devices, information technology, video conferencing and digital imaging standards and technologies, which help to overcome the distance barrier in the delivery of care. Telehealth is reeving active government support through funding and policies as it is cost-effective accessible, affordable for the majority of the population, which is positively impacting the market.

The report provides qualitative and quantitative insights on the telehealth industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market segments include type, application, modality, end user, and geography. On the basis of the type, the global market segments include products and services. Based on application, the global market is segmented into telemedicine, patient monitoring, continuous medical education, and others.

Based on modality, the global market is segmented into store-and-forward (asynchronous), real-time (synchronous) and, remote patient monitoring. Based on end user, the global market is segmented into healthcare facilities, homecare, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.

Along with this, the telehealth market report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the regulatory scenario for key countries, health reimbursement overview, telehealth services overview, new product launches, an overview of countries with telehealth policies, technological advancements, recent industry developments such as mergers & acquisitions, and others.

SEGMENTATION

 SEGMENTATION

 

By Type

  • Products
  • Services

By Application

  • Telemedicine
  • Patient Monitoring
  • Continuous Medical Education
  • Others

By Modality

  • Store-and-forward (Asynchronous)
  • Real-time (Synchronous)
  • Remote Patient Monitoring

By End User

  • Healthcare Facilities
  • Homecare
  • Others

By Geography

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Telehealth market Key Industry Developments

In April 2019, InTouch Health announced the launch of Solo, an end-to end fully integrated virtual care platform, which is suitable for any user type in any healthcare setting.

In April 2018, Comcast partnered with Independent Health Group for development of a new patient care and communication platform.

In April 2018, American Well acquired AVIZIA LIMITED which will provide America Well with comprehensive capabilities for acute care including custom software for various specialties and cart line-up.

 

Looking for more? Check out our repository for all available reports on Telehealth in related sectors.

Quick Read Table of Contents of this Report @ Telehealth Market Size, Share and Industry Analysis By Type (Products, Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Remote Patient Monitoring), By End User (Healthcare Facilities, Homecare, Others), and Geography Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global sugar substitutes market size was USD 6.35 billion in 2018, is projected to reach USD 10.27 billion by the end of 2026, exhibiting a CAGR of 6.3% in the forecast period.

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Sugar Substitutes market.

Trusted Business Insights presents an updated and Latest Study on Sugar Substitutes Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Sugar Substitutes market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Sugar Substitutes Market Size, Share and Global Trend By Type (Aspartame, Acesulfame potassium, Saccharine, Sucralose, Stevia, Sugar Alcohols, and Others), Application [Food and Beverage (Table-top, Beverages, Bakery & Confectionery, and Other Processed Foods), Pharmaceuticals, and Personal Care and Cosmetics), and Geography Forecast till 2029 (Includes COVID-19 Business Impact)

The global sugar substitutes market size was USD 6.35 billion in 2018, is projected to reach USD 10.27 billion by the end of 2026, exhibiting a CAGR of 6.3% in the forecast period.

We have updated the Sugar Substitutes Market with business impact analysis and disruption caused by COVID-19.
Inquire before buying

Sugar substitutes are basically the food additives that can replicate the effect of sugar in taste but usually have less food energy/calories. The popularity of sugar substitutes has surged owing to the consumers perception and realization of energy imbalance between calories consumed and calories expended -this imbalance in food calories is due to factors such as growing urbanization, enhancement in the discretionary spending on the processed foods and beverages, sedentary lifestyles which have collectively led to increased incidences of lifestyle disorders.This trend has prompted consumers to opt for suitable sugar substitutes that do not contribute to overall calories consumed. The sugar substitutes global market size is also set to experience significant transition owing to all-natural trend resonating in global marketplace, the companies in market are also set to sense the pulse of this demand dynamics and reciprocating it with innovative sugar substitutes and related products and solutions that are not only minimally-processed but also contain clean-label traits aligning with the sustainable consumption practices.The World Health Organization (WHO) has reported that excessive sugar consumption is a risk factor for obesity, diabetes, and cardiovascular diseases (CVDs). The WHO has also decreased its recommendation for the consumption of added sugars from 5 to 10 percent of the energy component in the daily diet.Many scientific and clinical studies have linked excessive sugar consumption to the increased risks for certain degenerative diseases such as obesity, diabetes, and heart disease -thus the robust consumers inclination towards reduced-sugar in their diet and increasing demand for sugar substitutes have been major propellers for the sugar substitutes market revenue.

“”Natural Sugar Substitutes that Enhances Sweet Perceptions Are Projected to Grow at a faster rate as compared to Synthetic/Artificial Intense Sweeteners””The sugar substitutes have initially thrived on synthetic alternatives for sucrose such as Saccharine, Aspartame, and Acesulfame potassium to name but a few -these sugar alternatives have enjoyed market dominance due to robust consumption patterns and strong demands from developed markets. The global market for sugar substitutes is now undergoing distinctive transition -robust popularity of clean-labeling has brought natural sweeteners such as stevia and monk fruit gain greater sales momentum.Apart from taste concerns, the other functionality of sucrose is being achieved by the addition of soluble fibers which act as a bulking agent with sugar substitutes without significantly affecting the sensory properties of food matrices. Companies in the sugar substitutes market such as Roquette have already started working in developing sugar substitutes -the firm has developed a range of Nutriose soluble fibers which contains half as many calories (2kcal/g) as sugar and offers a reliable and clean-label solution for sugar reduction projects. Cargill has also expanded its sugar-reduction strategy from beverages to bakery, convenience, snacks, sports nutrition, and confectionery. To know how our report can help streamline your business, Speak to Analyst var get_chart_name1= “”Global Sugar Substitutes Market Share for

Regional Analysis

“”Asia Pacific Region remains the Fastest Growth Market for Sugar Substitutes during 2019-2026″”The developed markets of North America and Western Europe continue to dominate the sugar substitutes market growth. One important regulatory and the policy-level initiative has been sugar taxes, that came into force in several markets in 2018, this has prompted reformulation across many processed food segments and spurred innovation in sugar substitutes. The sugar-reduction and consequently the reformulation has taken the center-stage with a rapid rise in the number of companies offering less sugar while retaining a similar taste and texture.The developing markets of Asia Pacific and Middle East and Africa are expected to witness sugar substitute sales growth well above the global average. Sugar-reduction is no longer a trend but a norm in the global food & beverage industry as this is known to align positively with consumers purchasing patterns. Manufacturers in the sugar substitute market share are prompted to significantly reduce sucrose levels in bakery, beverages, breakfast cereals, and even infant nutrition.Beverages are one of the largest segments where sugar reduction is intensively taken-up. Apart from consumer demand for reduced-sugar products and increasing preference for sugar substitutes, there has also been an increasing call for governments and regulatory bodies for keeping the sugar consumption in check. North America Sugar Substitutes Market, 2018

segmentation(get_label12,get_values2,chartid);””Beverages and Table-top among the Leading Application for Sugar Substitutes -Improvisation in Sensory Aspects remains a key for the future growth””Consumers nowadays are seeking ways to maintain a healthy lifestyle, and sugar remains top-of-mind in terms of health and wellness needs. Evolving consumers opinion towards table sugar has resulted in many multinationals expanding their portfolio of sugar-reduced or sugar-free options, which augurs well for the sugar substitutes market.The sugar-reduction concept has effectively taken a stronghold in the product categories with higher sugar content levels, viz. beverages, bakery, and confectionery, resulting in higher adoption rates of sugar substitutes.Beverages continue to hold dominance among the application areas of sugar substitutes owing to the consumers demand for low-calories formulations. Moreover, the shift towards natural positioning, organic, functional, and highly convenient beverages is expected to strengthen the market sentiments for the alternative sweeteners, especially for the natural ones derived from stevia, monk fruit, agave, etc.The future growth in the sugar substitute market report gives opportunities lies in innovative sugar substitutes and ingredients that offer taste along with the health benefits.Report CoverageThe global market for sugar substitutes is primarily driven by expanding application spectrum – from being limited to tabletop packets and diet soft drinks, these sugar substitutes are increasingly incorporated in the products such as baked commodities, ketchup, jams, cereals, snack bars, flavored waters, and dairy products including sugar-free yogurts, no-sugar-added ice cream, and flavored milk.Sugar substitutes also find application in dietary supplements, medications, and hygiene homecare products such as toothpaste and mouthwash, boosting the sugar substitutes market revenue.The market report on sugar substitutes provides qualitative and quantitative insights on the market and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented by type, application, and geography. On the basis of type, the sugar substitutes industry is categorized into aspartame, acesulfame potassium, saccharine, sucralose, stevia, sugar alcohols, and others.Based on the application, the market is segmented into food and beverage applications (includes table-top, beverages, bakery & confectionery, and other processed foods), pharmaceuticals, and personal care and cosmetics. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. The regions are further categorized into countries. To gain extensive insights into the market,

Along with this, the report provides an elaborative analysis of the sugar substitutes dynamics and competitive landscape for sugar substitutes. Various key insights provided in the report are the overview of related markets, recent industry developments such as mergers & acquisitions, the regulatory scenario in key countries, and key industry trends.

SEGMENTATION ATTRIBUTE DETAIL

By Type Aspartame

Acesulfame potassiumSaccharineSucraloseSteviaSugar AlcoholsOthersBy ApplicationFood and BeverageTable-topBeveragesBakery & ConfectioneryOther Processed FoodsPharmaceuticalsPersonal Care and CosmeticsBy GeographyNorth America (U.S., Mexico, Canada, and Rest of North America)Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe)Asia Pacific (Japan, China, India, Australia, and Rest of Asia Pacific)South America (Brazil, Argentina, and Rest of the South America)Middle East & Africa (UAE, South Africa, and Rest of the Middle East & Africa)Key companies covered in the reportTate & LyleCargill, IncorporatedArcher Daniels Midland CompanyIngredion IncorporatedRoquette FrèresThe Nutra Sweet CompanyAjinomoto Co., Inc.JK Sucralose Inc.DowDuPontPure Circle LimitedOther Key Market Players

KEY INDUSTRY DEVELOPMENTS

In June 2019, Pioneer Foods entered into a joint venture to launch a sweetener viz. Freesweet, developed by Durbanite, Deborah Good. It is a proprietory blend of erythritol xylitol, and inulin.In February 2019, Tata Chemicals has launched Tata Nx product contains Zero Sugar and 100% natural sweetener made from stevia herb extract and lactose (used as a bulking agent).In May 2018, Tate & Lyle PLC entered into an agreement to acquire a 15% equity holding in Sweet Green Fields (stevia ingredient firm). The deal was aimed to strengthen the company leading portfolio of stevia-based ingredients and solutions.

 

Looking for more? Check out our repository for all available reports on Sugar Substitutes in related sectors.

Quick Read Table of Contents of this Report @ Sugar Substitutes Market Size, Share and Global Trend By Type (Aspartame, Acesulfame potassium, Saccharine, Sucralose, Stevia, Sugar Alcohols, and Others), Application [Food and Beverage (Table-top, Beverages, Bakery & Confectionery, and Other Processed Foods), Pharmaceuticals, and Personal Care and Cosmetics), and Geography Forecast till 2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global regenerative medicine market size was USD 23,841.5 Million in 2018 and is Projected to Reach USD 151,949.5 Million by 2026, Exhibiting a CAGR of 26.1% between 2019 and 2026.

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Regenerative Medicine market.

Trusted Business Insights presents an updated and Latest Study on Regenerative Medicine Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Regenerative Medicine market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Regenerative Medicine Market Size, Share and Industry Analysis By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Regional Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

The global regenerative medicine market size was USD 23,841.5 Million in 2018 and is Projected to Reach USD 151,949.5 Million by 2026, Exhibiting a CAGR of 26.1% between 2019 and 2026.

We have updated Regenerative Medicine Market with respect to COVID-19 Impact.
Inquire before buying

Regenerative medicine (RM) involves using cells, tissues, or genetic material to treat and manage diseases. Regenerative medicine is an emerging field that aims to repair, replace or regenerate damaged tissue or organ. The U.S. National Institutes of Health includes cell therapy, gene therapy, biomaterials and tissue engineering into regenerative medicine. Regenerative medicine holds potential to treat incurable chronic diseases and conditions such as Alzheimer disease, Parkinsons disease, diabetes and others. According to the Alliance for Regenerative Medicine, approximately around 1,028 clinical trials are ongoing on regenerative medicine worldwide. Around USD 13.3 Bn global financing were raised in 2018 by investment into regenerative medicine. The increased investment by key market players in the research and development of the regenerative medicine is one of the major factor anticipated to drive the regenerative medicine market growth during the forecast period.

Market Segmentation

“”Increased investment in the research and development of regenerative by the key market players is one of the major factor driving the global market””

Increasing investment by private and government organization in the development of the regenerative medicine is one of the factors expected to propel regenerative medicine industry dynamics. For instance, in March 2018, SanBio Group signed an agreement with Hitachi Chemical Advanced Therapeutics Solutions, LLC for the development and contract manufacturing of regenerative medicines. Rising prevalence of chronic and genetic disorders and increased healthcare expenditure by developed and developing countries are some of the key factors impelling the regenerative medicine market growth.

Additionally, presence of the strong product pipeline in stem cell and gene therapy by various research institutes and key market players is one if the major factor anticipated to boost the growth of the market during the forecast period of 2018-2026. However, the growing demand for organ transplantation in developed and developing countries and the commercialization of regenerative medicine are some of the key elements anticipated to supplement the growth of the regenerative medicine market trends throughout the forecast period. Increased use of skin substitutes, grafts, bone matrix and other tissue engineered regenerative medicine is one of the prominent factor for the growth of the market.

Based on the type, the regenerative medicine industry segments includes cell therapy, gene therapy, tissue engineering, and platelet rich plasma. On the basis of the application, the market is segmented into orthopedics, wound care, oncology, and others.

On the basis of distribution channel, the global regnerative medicine segments includes hospitals, clinics, and others. Cell therapy segmented is expected to register comparatively high CAGR during the forecast period due to increased research and product development in the field of stem cells.
Regional Analysis

“”Asia Pacific is anticipated to register comparatively higher CAGR during the forecast period due to increased adoption of the platelet rich plasma therapy and growing awareness among the population about stem cell therapy and regenerative medicine””

North America generated maximum revenue of USD 9,128.2 Mn in 2018 and is expected to dominate the market throughout the forecast period. Due to presence of substantial number of key market players based in U.S., presence of research institutes involved in development of novel therapeutics and availability of advanced technologies are attributive to the high number of clinical trials in North America. Asia Pacific is anticipated to witness exponential growth during the forecast period owing to expansion of infrastructure and facilities to accelerate stem cell research in developing countries. In April 2013, the Japan Ministry of Health, Labor and Welfare approved Regenerative Medicine law.

Asia Pacific Regenerative Medicine Market Size, 2018

The imposition of the law increased the number of the clinical development of regenerative and cell-based therapies. This led to drive the growth of the regenerative medicine market in the region. Additionally, Chinese government has approved several research related to human embryonic stem cells in order to encourage researchers to explore the clinical potential of these cells in China. Furthermore, rising aging population, increasing medical needs, and changing lifestyle are some of the other factors influencing the growth of the global regenerative market in the Asia Pacific region. Latin America, and Middle East & Africa region hold large potential for the market during 2019-2026.

Key Market Drivers

“”CELGENE CORPORATION, Medtronic, and American CryoStem Corporation Account for the Highest Market Share in Terms of Revenue””

CELGENE CORPORATION, is a leading player in the global regenerative medicines, owing to its strong portfolio in wound care and orthopedics and more investment in the research and development of the regenerative medicine. In order to strengthen the market position, key market players are focusing on the introduction of organ development and treatment of chronic diseases in the global market. CELGENE CORPORATION, Medtronic, and American CryoStem Corporation, dominated the regenerative medicine market in 2018. Other players operating in the market are Avita Medical, Osiris Therapeutics, Inc., Tissue Regenix, Wright Medical Group N.V., Smith & Nephew, Integra LifeSciences Corporation and others.

List of Companies Profiled

Report Coverage

The potential to directly alter human genes was first recognized nearly more than 50 years ago. Cell and gene therapy, represent overlapping fields of biomedical research with similar therapeutic goals. Regenerative medicine also comprises of therapeutic tissue engineering and biomaterials – engineered substances used in medical applications to supplement or replace a natural body function. The increased number of the clinical trials and the use of the regenerative medicine for the development of the medicine to treat chronic diseases are some of the factors propelling the regenerative medicine market trends.

The report provides qualitative and quantitative insights on the regenerative medicine industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market is segments include type, application, distribution channel, and geography. On the basis of the type, the market is segmented into cell therapy, gene therapy, tissue engineering and platelet rich plasma. On the basis of the application, the market is segmented into orthopedics, wound care, oncology and others. On the basis of distribution channel, the regenerative medicine market is segmented into hospitals, clinics and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.

Along with this, the regenerative medicine market report comprises analysis of the industry dynamics and competitive landscape. Various key insights provided in the report are prevalence and incidence of diabetes by key countries, advancements in insulin delivery devices, recent industry developments such as mergers & acquisitions, pricing analysis, technological advancements, and key industry trends.

SEGMENTATION

By Product

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Platelet Rich Plasma

By Application

  • Orthopedics
  •  Wound Care
  • Oncology
  • Others

By Distribution Channel

  • Hospitals
  •  Clinics
  • ·Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Developments

In 2018, Novartis received EU approval for one-time gene therapy Luxturna, which has been developed to restore vision in people with rare and genetically-associated retinal disease.

In 2018, Novartis received EU approval for its CAR-T cell therapy, Kymriah.
In 2017, Integra LifeSciences launched its product, Integra Dermal Regeneration Template Single Layer “”Thin”” for dermal repair defects reconstruction in a one-step procedure.

 

Looking for more? Check out our repository for all available reports on Regenerative Medicine in related sectors.

Quick Read Table of Contents of this Report @ Regenerative Medicine Market Size, Share and Industry Analysis By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Regional Forecast, 2020 – 2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global crawler dozers market size was USD 6.19 billion in 2018 and is projected to reach USD 10.04 billion by 2026, exhibiting a CAGR of 6.3% during the forecast period.

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Crawler Dozers market.

Trusted Business Insights presents an updated and Latest Study on Crawler Dozers Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Crawler Dozers market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Crawler Dozers Market Size, Share & Industry Analysis, By Horsepower (Less than 300 HP, 300 – 600 HP & More than 600 HP), By Application (Construction, Mining, Agriculture & Others), and Regional Forecast, 2020-2029 (Includes COVID-19 Business Impact)

The global crawler dozers market size was USD 6.19 billion in 2018 and is projected to reach USD 10.04 billion by 2026, exhibiting a CAGR of 6.3% during the forecast period.

We have updated Crawler Dozers Market with respect to COVID-19 Impact.
Inquire before buying

Crawler dozers are continuous trailed machines fixed with a front-mounted spade to move or shove large quantities of material such as sand, soil and rubble. They play a dynamic role in transportation and movement of materials across different land grades. Crawler dozers are crucial in overload shedding and heaving during road maintenance. Owing to the crawlers (tracks), the dozers have good ground-holding ability plus agility even in rough terrains. They are wide enough so that the load is distributed across the machine, averting it from tumbling even on soft terrains. All these uses makes them a good choice for numerous applications in construction, road building, and land clearing.

Modern versions of crawler dozers are improved and altered with specific mechanisms so as to meet the demands. The equipment is installed with more sophisticated tools to make the work more efficient and effective. Some of the modern mechanisms installed are automatic transmissions, hydraulic cylinders, and automatic grade control options.

MARKET DRIVER

Innovative Technologies Introduced in the Machines are Proposed to Propel the Market
Innovative technologies embedded in crawler dozers is expected to propel the crawler dozers market growth. The technologies, which include sensors, joysticks, power controls, power steering, power breaks, among others, are assisting in increasing efficiency of work. These new technologies help in effectively controlling the machines with the loads intact on it. This will enhance the outcome along with aiding in improving the work quality. Furthermore, smart technologies include smart grade control embedded with sensors which helps in generating approximately 100 corrections for every second.

Modern technology is assisting in improved outcomes and, additionally, it helps the inexperienced operators to handle specific grades, while grading at the job site. With the help of these technologies, naive operators can gain skills to operate crawler dozers within a short period of time. Moreover, use of these new and smart technologies is expected to enhance the job site accuracy along with work quality and efficiency. Therefore, these advanced technologies offer effortless operation of machines and are expected to drive the growth of the market.

SEGMENTATION
By Horsepower Analysis

300 -600 HP Crawler Dozers Likely to Generate Significant Revenue

Based on horsepower, the market is segmented into less than 300 HP, 300 – 600 HP, and more than 600 HP.
The 300 -600 HP crawler dozers are expected to have a significant market share during the forecast period. This sub-segment consists of machines that are suitable for a variety of grades and provide appropriate control. The growth of this types of dozers is also expected to boost the sales as these are not limited to one application.
More than 600 HP crawler dozers are expected to show moderate growth during the forecast period, due to their classified applications in construction and mining. These crawlers are used at places where there is a need for more power so as to produce better layout or move heavy material. Furthermore, less than 300 HP dozers are expected to show steady growth during the forecast period. These dozers provide smooth sorting of materials with the necessary density, thus resulting in better interlocking of materials at concentrated places. This has augmented the use of dozers at small agricultural lands, commercial properties, etc.

By Application Analysis

Construction Application Segment is to Have Prominent Market Growth
The application segment covered in this report includes construction, mining, agriculture and others which includes transportation.

Construction sub-segment is expected to propel the crawler dozers market revenue. In this application, the dozers are used for multiple purposes, such as grading, moving soils or other construction material from one place to another, among various other use cases. In addition, agricultural application of crawler dozers is expected to show steady growth during the period. This application is expected to intensify the growth of the market due to increasing agricultural activities.

Mining application is expected to show moderate growth due to overall decrease in the mining sector. The use of dozers is occasionally replaced with excavators or motor graders, which is likely to slow-down the growth of the market. Likewise, the others sub-segment, which includes transportation, is expected to show moderate growth during the forecast period owing to the increasing use of other construction equipment such as excavators, graders, loaders, etc.

REGIONAL ANALYSIS

The scope of the report comprises of five major regions, namely North America, Europe, Asia Pacific, the Middle East & Africa and Latin America.

Europe generated a revenue of USD 1.63 billion in 2018 and is anticipated to emerge as the dominant region during the forecast period. The region is expected to hold a prominent section of the crawler dozers market share during the forecast period owing to the development of the construction industry in countries such as Germany, Italy, etc. However, Europe already utilizes modernized equipment, owing to which the market is expected to grow moderately in the coming future.

Europe Crawler Dozers Market Size, 2018 (USD Billion)

North America is projected to show steady growth in the forecast period. It is because the region is already saturated owing to the early adoption of the machines. Additionally, moderate progress of construction equipment sector due to economic slowdown is expected to hold back the crawler dozers market growth. Asia Pacific is anticipated to have highest growth rate during the forecast period. The governments of major economies, such as India and China, are investing huge amount of funds in infrastructure development projects at provincial/ state levels. This region also has a strong presence of Chinese players who offer these machines at relatively lower prices, thus resulting in higher market share for the forecast period.

Middle East & Africa and Latin America are expected to post steady growth during the forecast period. The growth is owed to the initiatives taken by the governments in these regions to increase infrastructural quality along with rising investments from the public as well private sector for infrastructural development. Furthermore, increasing mining expenditure is expected to fuel the crawler dozer market.

INDUSTRY KEY PLAYERS

Focused Efforts to Establish Presence in Developing Economies to Spur Competition
Leading players such as Shantui Construction Machinery co., Ltd, Caterpillar, Deere & Company, and LiuGong Dressta Machinery have a dominant position, holding approximately 78% share in this market. These manufacturers are focusing on setting up their plants in emerging and developing economies in order to maintain their presence in these regions. These economies are proving to be cost effective and high output regions for the companies, as they have abundance of resources coupled with government initiations to boost the manufacturing sector.

List of Key Companies Profiled:

  • Deere & Company
  • Caterpillar
  • Liebherr-International Deutschland GmbH
  • LiuGong Dressta Machinery
  • Shantui Construction Machinery Co., Ltd
  • Komatsu Ltd
  • CNH Industrial N.V

REPORT COVERAGE

The crawler dozers market report offers an in-depth analysis of the market. It further provides details on the adoption of crawler dozers across five major regions. Information on trends, drivers, opportunities, threats, and restraints of the market can further help stakeholders to gain valuable insights into the market. The report offers a detailed competitive landscape by presenting information on key players, along with their strategies, in the market.

Report Scope & Segmentation

Segmentation

By Horsepower

  • Less than 300 HP
  • 300 – 600 HP
  • More than 600 HP

By Application

  • Construction
  • Mining
  • Agriculture
  • Others (Transportation)

By Region

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, and Rest of Europe)
  • Asia Pacific (China, Japan, India, Southeast Asia, and Rest of Asia Pacific)
  • Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
  • Latin America (Brazil, Mexico, and Rest of Latin America)

INDUSTRY DEVELOPMENT:

July 2019: Deere & Company announced the launch of new 850L crawler dozer. This model is the successor of company™s famous K-series. 850L is equipped with 9litre JD engine which produces 225 HP and provides approximately 10% more power than the K-series.

February 2019: Caterpillar launched a D5 medium size crawler dozer. This model will succeed the renowned D6N model. D5 is installed with 7.1litre engine which generates power of 170 HP.

 

Looking for more? Check out our repository for all available reports on Crawler Dozers in related sectors.

Quick Read Table of Contents of this Report @ Crawler Dozers Market Size, Share & Industry Analysis, By Horsepower (Less than 300 HP, 300 – 600 HP & More than 600 HP), By Application (Construction, Mining, Agriculture & Others), and Regional Forecast, 2020-2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
COVID-19 Industry Impact Latest Market Reports Market Price Analysis Market Study

Global point of care (POC) diagnostics market size was valued at USD 17,019.5 Million in 2018 and projected to reach USD 28,379.6 Million by 2026, exhibiting at a CAGR of 6.6% during the forecast year.

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Point-of-Care Diagnostics market.

Trusted Business Insights presents an updated and Latest Study on Point-of-Care Diagnostics Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Point-of-Care Diagnostics market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Point of Care (POC) Diagnostics Market Size, Share and Industry Analysis By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

The global point of care (POC) diagnostics market size was valued at USD 17,019.5 Million in 2018 and projected to reach USD 28,379.6 Million by 2026, exhibiting at a CAGR of 6.6% during the forecast year.

We have updated Point-of-Care Diagnostics Market with respect to COVID-19 Impact.
Inquire before buying

Existing market players operating in the global point-of-care diagnostics market are focusing on constant innovation and up-gradation of their product portfolio with new and efficient product offerings for better and accurate diagnostics outcomes for the patients. One of the critical reasons for the growth of the global point of care testing market is the increasing demand for efficient diagnostics at the place of care such as intensive units for the patients, driven by the increasing number of medical procedures and the increasing number of hospitalizations. Rise in awareness regarding point-of-care diagnostics in both developing and developed nations, and the emergence of new products with advanced technologies and greater accuracies is propelling the growth of the global point of care diagnostics market.

This, coupled with, increasing investments by major players in research and development for new POC testing, are also boosting the growth of the market globally. The increased demand in the POC diagnostics market is also primarily driven by increased demand for diagnostics results in shorter periods than the traditional waiting times of days. Some of the other factors which are also contributing to the growth of the market are the increase in the medical and surgical procedures which require immediate results for critical decisions.
The introduction of new and advanced POC diagnostics such as Afinion HbA1c Dx test, a point of care diagnostic for the testing of diabetes by Abbott expected to drive the growth of the point of care testing market in developed as well as emerging countries, during the forecast period 2019-2026.

Market Segmentation

“”Blood Glucose Monitoring to Account for the Highest Market Share by 2026″”

Blood glucose monitoring is anticipated to account for the highest market share in the global point-of-care diagnostics market due to its status of diabetes as one of the most prevalent diseases. The new product launches for the blood glucose monitoring segment are driving the growth of the segment, and the same is expected to drive the growth of the market during the forecast period. Some of the other factors anticipated to drive the growth of the blood glucose monitoring segment are the constant requirement of regular testing for the treatment and management for the patients of diabetes and the increasing need for efficient testing in homecare settings.

The blood glucose monitoring segment accounted for a market share of 61.1% in 2018 and is expected to increase during the forecast period. In terms of considerations of ease of usage, blood glucose monitoring point-of-care (POC) diagnostics are preferred. These factors are also driving the growth of the blood glucose monitoring segment. The infectious diseases segment is estimated to grow at a faster CAGR during the forecast period. The infectious diseases segment is undergoing a growth due to the increase in the prevalence of infectious diseases. This is anticipated to fuel the growth of the segment during the forecast period.

Regional Analysis

“”Increasing Demand for Point-of-Care (POC) Testing for the Rapid and Accurate Diagnostic Outcomes Expected to Result in The Highest CAGR in the Asia Pacific””

North America generated a revenue of US$ 6,125.5 Mn in 2018 and is anticipated to account for a dominant share in the global POC testing market during the forecast period. Growth witnessed in the region is likely to be driven by the increasing demand for technologically advanced point-of-care (POC) diagnostics with increasing accuracy, which result in significantly in rapid point of care decisions. This is especially applicable in instances where there are critical medical cases where the individual requires immediate decisions for the treatment and management of serious disorders.
North America Point of Care (POC) Diagnostics Market Size, 2018

In emerging countries such as India and China, the rise in awareness regarding point-of-care (POC) diagnostics and the increasing demand for accurate diagnostics is fueling growth in rapid diagnostics market during the forecast period. In countries like China and India, due to the development of the healthcare infrastructure and increasing healthcare expenditure, new products are being launched. In Japan, there is a significant demand for POC diagnostics due to the demand and availability of advanced point-of-care (POC) Diagnostics and the high proportion of the geriatric population.

KeyMarket Drivers

“”F. Hoffmann-La Roche Ltd, To Be the Leading Player in The Point of Care Diagnostics Market””

F. Hoffmann-La Roche Ltd, emerged as the leading player with the highest market share in 2018, as the company has several technologically advanced and specialized products as per varied indications in its family of point-of-care (POC) diagnostics. This range has several point-of-care (POC) diagnostics according to various settings such as the emergency rooms, homecare, doctors offices, and personal use. Also, other market players are also launching new products such as Abbott, which recently launched the product offering of Afinion HbA1c Dx test. Other players operating in the rapid diagnostics market are Abbott, Johnson & Johnson Services, Inc., Becton, Dickinson and Company (BD), Quidel Corporation, Sekisui Diagnostics, Danaher, Siemens Healthcare GmbH, AccuBioTech Co., Ltd., Chembio Diagnostic Systems, Inc., EKF Diagnostics Holdings plc, Instrumentation Laboratory (A Werfen Company), Nova Biomedical, and ?PTS Diagnostics.

List of Companies Profiled

  • Abbott
  • Johnson & Johnson Services, Inc.
  • Becton, Dickinson and Company (BD)
  • Quidel Corporation
  • Sekisui Diagnostics
  • Danaher
  • Siemens Healthcare GmbH
  • AccuBioTech Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings plc
  • Instrumentation Laboratory (A Werfen Company)
  • Nova Biomedical
  • PTS Diagnostics

Report Coverage

The increasing demand for rapid diagnostics in the general population is one of the key factors driving the growth of the global point of care testing market. The increasing R&D initiatives in the POC diagnostics market and the recent product launches are also positively contributing to the growth of the market. The report on global market focuses on size in terms of revenue (US$ Mn), of rapid diagnostics, for the period 2015-2026.

The report offers information about various dynamics of the market, including drivers, restraints, opportunities for players in the point-of-care diagnostics market, and trends. The report analyzes and evaluates the current market size, growth rate, and forecast figure of the global market, with regards to the product, which is segmented into the blood glucose monitoring, infectious diseases, cardiometabolic diseases, pregnancy and fertility testing products, hematology testing products, and others. Based on the end-user, the market is categorized into hospital bedside, physicians office lab, urgent care & retail clinics, and home and self-testing.

The report also offers key insights related to an overview of POC diagnostics market (2018) – for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, overview of the number of point-of-care (POC) diagnostics procedures by key countries, overview of price analysis of types of rapid tests, overview of regulatory scenario by key countries, overview of reimbursement scenario by key countries, pipeline analysis, new product launches and key industry developments – mergers, acquisitions, and partnerships and key growth indicators of POC diagnostics market.

SEGMENTATION

By Product

  • Blood Glucose Monitoring
  • Infectious Diseases
  • Cardiometabolic Diseases
  • Pregnancy and Fertility Testing Products
  • Hematology Testing Products
  • Others

By End User

  • Hospitals Bedside
  • Physicians Office Lab
  • Urgent Care & Retail Clinics
  • Home and Self Testing

By Geography

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Key Industry Developments

In June 2019, Abbott announced the launch of Afinion HbA1c Dx test, a point of care (POC) diagnostic for the testing of diabetes

In May 2016, Koninklijke Philips N.V. announced the launch of a new handheld blood test called the Minicare I-20 for the rapid point-of-care diagnosis of heart attack

 

Looking for more? Check out our repository for all available reports on Point-of-Care Diagnostics in related sectors.

Quick Read Table of Contents of this Report @ Point of Care (POC) Diagnostics Market Size, Share and Industry Analysis By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580